Abbott Laboratories (Pakistan) Limited (KASE: ABOT)
Health Care · Pharmaceuticals · PK
PKRs911.28
+0.13% today · -23.5% 1Y
Abbott Laboratories (Pakistan) Limited (KASE: ABOT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $321.41M.
Over the last twelve months the share price has lost 23.5%, trading between 821.00 and 1.30K.
Tweenvest scores Abbott Laboratories (Pakistan) Limited across four factors: quality 82/100, value 69/100, growth 80/100, dividend 83/100. Its strongest factor is dividend.
ABOT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $321.41M
- Revenue (TTM)
- $271.55M
- P/E
- 10.74
- EPS
- 84.85
- Dividend yield
- 4.39%
- Beta (5Y)
- 0.16
- 52-week high
- PKRs1,304.00
- 52-week low
- PKRs821.00
- Avg volume (3M)
- —
- Shares outstanding
- 97.90M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.